Six-million grant for LUMC cancer research
Eight research proposals submitted by scientists of LUMC have been rewarded with a shared grant of over six million euros from the Dutch Cancer Society (KWF). The researchers will engage in fundamental and translational research on several types of cancer.
New therapy eliminates resistant bacteria
How can you treat bacterial infections that are resistant to antibiotics? It can be done with peptides: short chains of amino acids, the building blocks of proteins. Researchers of LUMC, AMC and the Netherlands Burns Association (Brandwondenzorg Nederland) have published articles about this therapy in the scientific journal Science Translational Medicine.
Data about genes and medication automatically combined in hospital system
Since 2005, doctors and pharmacists have been working on a guidance service in which medication should be prescribed based on the patient’s DNA profile. LUMC takes implementation of this knowledge a step further now that data about the genetic profiles of specific patients is automatically entered into the hospital’s prescription system. LUMC is the first hospital to work like this.
LUMC and Erasmus MC-Sophia test resuscitation table for preterm infants
A new prototype of a resuscitation table for neonates is unveiled at LUMC. The table will be used for phase-2 trials conducted by LUMC and Erasmus MC-Sophia. The aim is to test whether delayed cutting of the umbilical cord provides vulnerable, preterm infants with a better start. The table was designed and built by the Medical Technology Service Centre, on the initiative of neonatologist Arjan te Pas in collaboration with Frans Klumper of the department of Obstetrics.
LUMC starts screening older patients at A&E
As from 1 March, LUMC has implemented a new screening protocol for older patients arriving at the Accident & Emergency (A&E) department. The aim of the screening is to provide more direct and personalised care for this group of patients. “The new screening programme helps our care professionals provide optimal care”, says Anja Booijen, A&E nurse.
Transplantation speeds up development mini-kidney
Growing a mini-kidney from human skin cells is a marvellous achievement, but the laboratory version is not a fully-grown, functioning kidney. Researchers from Leiden and Australia transplanted one of these mini-kidneys under the renal capsule of a mouse and noticed that it grew into a more mature mini-organ, including blood vessels.
Opening of NeLL - all national eHealth initiatives under one roof
The Mayor of Leiden, Mr Lenferink, opened the National eHealth Living Lab (NeLL). In NeLL, LUMC aims to bring together all national eHealth initiatives. Niels Chavannes, professor of Primary Care Medicine, holding the chair of eHealth Applications in Disease Management: “Research is of course very important, but in this set-up, in which we test care applications in a laboratory setting together with health care consumers, eHealth will be incorporated in actual practice.”
Leiden specialists first in Europe to use fluorescence in removal of lung tumour
Recently, a very special technique was used at LUMC: a team of specialists from the departments of Thoracic Surgery and General Surgery and the Centre for Human Drug Research removed a lung tumour they had pinpointed using fluorescence. This is the first time this technique has been used in Europe in a patient with a lung tumour.
Jet Bussemaker appointed professor in Leiden
As from 1 July 2018, former Minister of Education, Culture and Science Jet Bussemaker will be affiliated as a professor to LUMC and Leiden University. She will be the holder of a new chair in ‘Science, Policy and Societal Impact, focussing on Healthcare’. In addition to her work at LUMC and LUMC Campus Den Haag, Jet Bussemaker will be employed for one day a week at the Faculty of Governance and Global Affairs of Leiden University in The Hague.
Green LUMC receives silver certifcate Milieuthermometer Zorg
At the beginning of September we received the silver certificate 'Milieuthermometer Zorg'. Thanks to green initiatives such as waste separation, organic food in the restaurant and a new energy-efficient laboratory. Read more about what the LUMC is doing about corporate social responsibility.
Royal award for stem cell expert Wim Fibbe
Professor of Hematology and Stem Cell Biology Wim Fibbe was appointed Knight in the Order of the Netherlands Lion on 12 October. He received the ribbon after his speech to say goodbye to his position as department head of Immunohaematology and Blood Transfusion. Fibbe will remain committed to research into regenerative medicine in the coming years.
LUMC takes lead in construction of stem cell facility
Over the next few years, Leiden BioScience Park will become the site of a brand-new high-tech stem cell facility: the Netherlands Centre for the Clinical Advancement of Stem Cell Therapies (NECST). The facility will welcome researchers and start-up firms that are working to develop stem cell and gene therapy products.
European grant for research on the use of artificial intelligence
LUMC researchers want to improve diagnosis and treatment of patients by using improved imaging, deep learning based analysis of imaging and non-imaging data combined with the adoption of new robotic tools. They received 1.1 million euro from the IMPACT subsidy.